Iritis is treated with two types of eye drops: anti-inflammatory drops to calm the inflammation and dilating drops to relieve pain and prevent complications. Most episodes resolve within a few weeks with proper treatment, but the drops need to be tapered gradually rather than stopped abruptly. If you suspect iritis, you need an eye exam before starting treatment, because the specific drop schedule depends on how much inflammation is present.
How Iritis Is Diagnosed
An ophthalmologist diagnoses iritis using a slit lamp, a microscope that shines a narrow beam of light into the front of your eye. The hallmark finding is white blood cells floating in the fluid behind your cornea, something you can’t see yourself but that’s clearly visible under magnification. The doctor also looks for “flare,” a hazy, turbid appearance in that same fluid caused by proteins leaking from inflamed blood vessels.
Both cells and flare are graded on a standardized scale from 0 to 4+, and these grades guide how aggressively the inflammation needs to be treated. The exam needs to happen before any dilating drops are given, because dilation can shed pigment into the eye and make the cell count harder to read. These same grades are used at follow-up visits to track whether treatment is working.
Anti-Inflammatory Eye Drops
Corticosteroid eye drops are the cornerstone of iritis treatment. The most commonly prescribed is prednisolone acetate 1%, which in moderate to severe cases may be started at a frequency of every one to two hours during waking hours. The exact schedule depends on the severity of inflammation your doctor sees on the slit lamp. A newer option, difluprednate 0.05%, achieves similar results at four times daily compared to prednisolone’s eight-times-daily schedule, which can make a real difference in convenience.
Once inflammation starts to improve, your doctor will reduce the frequency of drops in a slow, stepwise taper. This is one of the most important parts of treatment. Stopping steroid drops too quickly is a common cause of rebound inflammation, where the iritis flares right back up, sometimes worse than the original episode. A typical taper might reduce the drops by one dose per day every week or two, but the pace depends entirely on how your eye responds at each follow-up visit. Expect to use the drops for several weeks total, even if your eye feels better within days.
Dilating Drops for Pain Relief
The second essential component is a cycloplegic drop, which dilates your pupil and relaxes the muscles inside your eye. Iritis causes the small muscle that controls your pupil to go into spasm, which is a major source of the deep, aching pain people feel. By relaxing that muscle, the drop provides significant pain relief, often within minutes.
These drops also serve a protective purpose. When the iris is inflamed, it can stick to the lens sitting just behind it, forming adhesions called posterior synechiae. Once these form, they can permanently distort the pupil and interfere with fluid drainage inside the eye. Keeping the pupil dilated pulls the iris away from the lens and prevents this from happening. Commonly used options include cyclopentolate for milder cases and longer-acting agents for more severe inflammation.
While you’re on dilating drops, your near vision will be blurry and you’ll be more sensitive to light. These effects are temporary and resolve once the drops are stopped.
What Causes Iritis in the First Place
About half of all acute iritis cases are linked to a genetic marker called HLA-B27. This gene is strongly associated with inflammatory conditions affecting the spine and joints, and roughly 50 to 75% of people who have HLA-B27-related iritis also have an underlying condition like ankylosing spondylitis or reactive arthritis, even if they haven’t been diagnosed yet. If you have a first episode of iritis, your doctor may order blood work to check for HLA-B27 and related conditions, especially if you also have lower back stiffness or joint pain.
Other causes include infections (herpes viruses are a common culprit), trauma to the eye, and autoimmune diseases like sarcoidosis or inflammatory bowel disease. In many cases, no specific cause is found. Identifying an underlying trigger matters because it changes the long-term treatment strategy and helps predict whether the iritis is likely to come back.
When Drops Aren’t Enough
Most first episodes of iritis respond well to eye drops alone. But some people develop chronic or frequently recurring iritis that keeps flaring despite topical treatment. In these situations, doctors may escalate to systemic therapy.
The first step up is usually oral corticosteroids, which suppress inflammation throughout the body. These work quickly but carry significant side effects with long-term use, so the goal is always to taper off within a few months. If someone needs ongoing immune suppression to keep their iritis under control, their doctor will typically transition to a steroid-sparing medication. These include drugs that dial down the immune system’s overactivity more selectively, allowing the steroids to be reduced or stopped.
For severe or treatment-resistant cases, biologic medications that target specific parts of the immune system may be used. One biologic, adalimumab, is specifically approved for certain types of eye inflammation and is given as an injection under the skin every two weeks. The decision to use these therapies involves balancing the risk of the medications against the risk of permanent vision loss from uncontrolled inflammation.
Complications to Watch For
The most significant complication of iritis is elevated eye pressure, which can develop into secondary glaucoma. In a large study of uveitis patients, about 18% of affected eyes developed secondary glaucoma. This can happen from the inflammation itself, which clogs the eye’s drainage system with inflammatory debris, or from the steroid drops used to treat it. About 9% of secondary glaucoma cases in that study were attributed to the steroid treatment rather than the disease. This is why your ophthalmologist checks your eye pressure at every follow-up visit.
Cataracts are another long-term risk, particularly for people with chronic or recurrent iritis. Both the inflammation and prolonged steroid use contribute to lens clouding over time. Posterior synechiae, the adhesions between the iris and lens mentioned earlier, can also cause problems if they form a complete ring around the pupil, blocking fluid flow and causing a sudden dangerous spike in eye pressure.
What Recovery Looks Like
A single episode of acute iritis typically resolves within two to six weeks with proper treatment. You’ll have several follow-up appointments during this time so your doctor can check the cell count, measure eye pressure, and adjust your drop schedule. Most people notice the pain and light sensitivity improve substantially within the first few days of treatment, but visible inflammation on the slit lamp takes longer to clear.
The taper period is where many people run into trouble. Your eye may feel completely normal while there’s still low-grade inflammation present, and cutting the drops too fast at this stage invites a rebound flare. Follow the tapering schedule even when your eye feels fine. If iritis does recur, it tends to affect the same eye and follow a similar pattern, which helps your doctor plan a treatment approach more quickly the next time around.
People with HLA-B27-related iritis have a particularly high recurrence rate. If you’re experiencing multiple flares per year, that’s usually the point where your ophthalmologist and possibly a rheumatologist will discuss long-term immune-suppressing therapy to break the cycle and reduce the cumulative damage to your eye.